|
|
Volumn 134, Issue 5 II, 1997, Pages
|
|
Rationale for low-molecular weight heparin in coronary stenting
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
ANTICOAGULANT AGENT;
COUMARIN ANTICOAGULANT;
ENOXAPARIN;
HEPARIN;
LOW MOLECULAR WEIGHT HEPARIN;
TICLOPIDINE;
WARFARIN;
ANIMAL MODEL;
ANTICOAGULANT THERAPY;
CARDIOVASCULAR DISEASE;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CORONARY ARTERY DISEASE;
DOUBLE BLIND PROCEDURE;
GASTROINTESTINAL SYMPTOM;
HUMAN;
INTERVENTIONAL RADIOLOGY;
ISCHEMIC HEART DISEASE;
MAJOR CLINICAL STUDY;
NONHUMAN;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
RASH;
STENT;
SUBCUTANEOUS DRUG ADMINISTRATION;
THROMBOEMBOLISM;
TRANSLUMINAL CORONARY ANGIOPLASTY;
TREATMENT OUTCOME;
|
|
EID: 0031457564
PISSN: 00028703
EISSN: None
Source Type: Journal
DOI: 10.1016/s0002-8703(97)80054-3 Document Type: Conference Paper |
|
Times cited : (11)
|
|
References (38)
|
